Currently, the clinical outcome of NB is mainly predicted based on age, tumor stage, mitotic nuclear rupture index, MYCN (Neuroblastoma MYC Oncogene) amplification and ALK (Anaplastic Lymphoma Kinase) expression [3,4]. The gene discussed is MYCN; the disease is neuroblastoma.